India to Uzbekistan: Cyclophosphamide Export Trade Route
India has recorded 9 verified shipments of Cyclophosphamide exported to Uzbekistan, representing a combined trade value of $157.4K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $17.5K USD. The leading Indian exporter is VIVALIA REMEDIES PRIVATE LIMITED, which accounts for 66% of total export value with 2 shipments worth $104.6K USD. On the buying side, LLC "OPTI FARM" is the largest importer in Uzbekistan with $104.6K USD in purchases. The top 3 suppliers — VIVALIA REMEDIES PRIVATE LIMITED, VIVALIA REMEDIES PRIVATE LIMITED , APRAZER HEALTHCARE PRIVATE LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Uzbekistan Cyclophosphamide corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $157.4K USD. The route is dominated by VIVALIA REMEDIES PRIVATE LIMITED, which alone accounts for roughly 66% of all export value, reflecting the consolidated nature of India's cyclophosphamide manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $17.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with cyclophosphamide's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 21.0%, placing it at rank #16 among India's top cyclophosphamide export destinations globally.
On the import side, key buyers of Indian cyclophosphamide in Uzbekistan include LLC "OPTI FARM", LLC "OPTI FARM" , TO THE ORDER OF and 1 others. LLC "OPTI FARM" is the single largest importer with 2 shipments valued at $104.6K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ2
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#16
- Annual growth+21.0%
- Demand growth+19.7%
- Regulatory ease75/100
Top 10 Indian Cyclophosphamide Exporters to Uzbekistan
Showing top 10 of 4 Indian suppliers exporting Cyclophosphamide to Uzbekistan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VIVALIA REMEDIES PRIVATE LIMITED Avg $52.3K per shipment | 2 | $104.6K | 66.5% |
| 2 | VIVALIA REMEDIES PRIVATE LIMITED Avg $21.6K per shipment | 2 | $43.2K | 27.4% |
| 3 | APRAZER HEALTHCARE PRIVATE LIMITED Avg $2.8K per shipment | 3 | $8.4K | 5.3% |
| 4 | GALAXY SUPER SPECIALITY Avg $608 per shipment | 2 | $1.2K | 0.8% |
This table shows the top 10 of 4 Indian companies exporting cyclophosphamide to Uzbekistan, ranked by total trade value. The listed exporters are: VIVALIA REMEDIES PRIVATE LIMITED, VIVALIA REMEDIES PRIVATE LIMITED , APRAZER HEALTHCARE PRIVATE LIMITED, GALAXY SUPER SPECIALITY. VIVALIA REMEDIES PRIVATE LIMITED is the dominant supplier with 2 shipments worth $104.6K USD, giving it a 66% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Top 10 Cyclophosphamide Importers in Uzbekistan
Showing top 10 of 4 known buyers in Uzbekistan receiving Cyclophosphamide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian cyclophosphamide in Uzbekistan include LLC "OPTI FARM", LLC "OPTI FARM" , TO THE ORDER OF, IMDODI SHIFO LLC. The largest importer is LLC "OPTI FARM", accounting for $104.6K USD across 2 shipments — representing 66% of all cyclophosphamide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LLC "OPTI FARM" | 2 | $104.6K | 66.5% |
| 2 | LLC "OPTI FARM" | 2 | $43.2K | 27.4% |
| 3 | TO THE ORDER OF | 3 | $8.4K | 5.3% |
| 4 | IMDODI SHIFO LLC | 2 | $1.2K | 0.8% |
Top 10 Cyclophosphamide Formulations Imported by Uzbekistan
Showing top 10 of 8 product formulations shipped on the India to Uzbekistan Cyclophosphamide route, ranked by trade value
Uzbekistan imports a wide range of cyclophosphamide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CYCLOPHOSPHAMIDE INJ 200 MG, B.NO: 5GCY02,5GCY03,5GCY07,5GCY08,5GCY09, MFG DT:01/2025 & 03/2025, EXP DT:12/2026 &02/2027 — accounts for $57.1K USD across 1 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CYCLOPHOSPHAMIDE INJ 200 MG, B.NO: 5GCY02,5GCY03,5GCY07,5GCY08,5GCY09, MFG DT:01/2025 & 03/2025, EXP DT:12/2026 &02/2027 | 1 | $57.1K | 36.3% |
| 2 | CYCLOPHOSPHAMIDE FOR INJ.USP 200MG, BT.NO.5GCY10, MFG.03/25, EXP.02/27, BT.NO.5GCY11 TO 5GCY14, MFG.04/25, EXP.03/27 | 1 | $47.5K | 30.2% |
| 3 | CYCLOFOSFAN-GETWELL (CYCLOPHOSPHAMIDE FO | 2 | $43.2K | 27.4% |
| 4 | NUPHOS 200 INJ CYCLOPHOSPHAMIDE 213 80 MG B N 325 221 MFG 02 25 EXP 01 27 | 1 | $5.8K | 3.7% |
| 5 | NUPHOS 1000 INJ CYCLOPHOSPHAMIDE 1.069 MG B/N-325-193 MFG-02/25 EXP-01/27 | 1 | $1.6K | 1.0% |
| 6 | NUPHOS 200 INJ CYCLOPHOSPHAMIDE 213.80 MG B/N-325-192, MFG-02/25, EXP-01/27 | 1 | $985 | 0.6% |
| 7 | CYCLOXAN 1GM INJ CYCLOPHOSPHAMIDE INJ IP1000 MG BATCH-23FCP03 MANUFACTURING -06/23 EXP-05/25 | 1 | $942 | 0.6% |
| 8 | CYCLOSTED 200 MG INJ CYCLOPHOSPHAMIDE INJ IP 200 MG BATCH-HHP23003 MANUFACTURING -03/23 EXP-02/25 | 1 | $274 | 0.2% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 6 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's cyclophosphamide exports to Uzbekistan are driven primarily by a handful of large-scale manufacturers. VIVALIA REMEDIES PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Uzbekistan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — VIVALIA REMEDIES PRIVATE LIMITED, VIVALIA REMEDIES PRIVATE LIMITED , APRAZER HEALTHCARE PRIVATE LIMITED — together account for 99% of total trade value on this route. The average shipment value of $17.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as cyclophosphamide for inj.usp 200mg, bt.no.5gcy10, mfg.03/25, exp.02/27, bt.no.5gcy11 to 5gcy14, mfg.04/25, exp.03/27 and cyclofosfan-getwell (cyclophosphamide fo , suggesting that buyers in Uzbekistan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LLC "OPTI FARM" is the largest importer with 2 shipments worth $104.6K USD — representing 66% of all cyclophosphamide imports from India on this route.
Route Statistics
- Trade Volume
- $157.4K
- Avg. Shipment
- $17.5K
- Suppliers
- 4
- Buyers
- 4
- Transit (Sea)
- ~21 days
- Annual Growth
- +21.0%
Related Analysis
Other Cyclophosphamide Routes
Unlock the Full India to Uzbekistan Cyclophosphamide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 9 shipments on this route.
Frequently Asked Questions — India to Uzbekistan Cyclophosphamide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Cyclophosphamide to Uzbekistan?
The leading Indian exporters of Cyclophosphamide to Uzbekistan are VIVALIA REMEDIES PRIVATE LIMITED, VIVALIA REMEDIES PRIVATE LIMITED , APRAZER HEALTHCARE PRIVATE LIMITED. VIVALIA REMEDIES PRIVATE LIMITED holds the largest market share at approximately 66% of total trade value on this route.
Q What is the total value of Cyclophosphamide exports from India to Uzbekistan?
India exports Cyclophosphamide to Uzbekistan worth approximately $157.4K USD across 9 recorded shipments. The average value per shipment is $17.5K USD.
Q Which ports does India use to ship Cyclophosphamide to Uzbekistan?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 6 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Uzbekistan for Cyclophosphamide?
The average transit time for Cyclophosphamide shipments from India to Uzbekistan is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Uzbekistan Cyclophosphamide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.0% with demand growth tracking at 19.7%. The route is ranked #16 among India's top Cyclophosphamide export destinations globally.
Q How many suppliers are active on the India to Uzbekistan Cyclophosphamide route?
There are currently 4 active Indian suppliers exporting Cyclophosphamide to Uzbekistan. The market is moderately concentrated with VIVALIA REMEDIES PRIVATE LIMITED accounting for 66% of total shipment value.
Q Who are the main importers of Cyclophosphamide from India in Uzbekistan?
The leading importers of Indian Cyclophosphamide in Uzbekistan include LLC "OPTI FARM", LLC "OPTI FARM" , TO THE ORDER OF, IMDODI SHIFO LLC. LLC "OPTI FARM" is the largest buyer with 2 shipments worth $104.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Uzbekistan export trade corridor identified from Indian Customs (DGFT) records for Cyclophosphamide.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 4 importers in Uzbekistan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 9 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists